Nancy Bradish Myers

Head of Regulatory Strategy at Bryn Pharma

Nancy Bradish Myers, JD, Founder & CEO of Catalyst Healthcare Consulting, is a sought-after leader with deep expertise in health care law, regulation, and policy. She has led a successful strategic regulatory and reimbursement policy consultancy for the past 17 years.

Ms. Myers combines strategic vision and substantive regulatory expertise. She has run strategic plays and regulatory policy initiatives for a diverse range of clients, from small start-ups and venture capitalists to large corporations, associations and non-profits.

One of her signature skills is the ability to pull together teams of experts and allies, motivate them to bring their best thinking, and drive strategic wins. She is expert at developing cross-functional strategies and helping companies execute to create successes across the drug, biologics/gene therapy and medtech worlds.

Ms. Myers is an attorney and has been an active player in the Washington, DC policy arena for the past three decades; her prior leadership positions spanned the federal government (FDA, Capitol Hill), drug/biotech industry associations (PhRMA, BIO), health insurance and the equity research/investment world. At FDA, she served as special assistant and senior strategic advisor in FDA’s Office of the Commissioner.

Ms. Myers has also held leadership positions on not-for-profit Boards for the past 15 years, including at the Alliance for a Stronger FDA and the FDA Alumni Association. She has received FDA’s Distinguished Alumni Award and the John C. Villforth FDAAA Founders Award. She earned her BS from Duke University and her JD from Temple University School of Law.

Timeline

  • Head of Regulatory Strategy

    Current role